Literature DB >> 2545338

Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3.

E F Hays1, G C Bristol, S McDougall, J L Klotz, M Kronenberg.   

Abstract

A chronological study of the individual thymic lobes of young AKR mice after neonatal inoculation of the oncogenic AKR retrovirus SL 3-3 was performed. 100% of mice treated in this manner develop lymphoma between 60 and 100 days of age. A search for early lymphoma cells in individual thymi was carried out by inoculating the thymocytes subcutaneously in syngeneic and intrathymically in syngeneic and semisyngeneic recipients. Tumor progression was observed in animals between 48 and 60 days of age. These animals have: (a) normal weight lobes, in which no lymphoma cells could be detected, (b) thymus-dependent lymphoma cells, in one or both normal weight lobes; (c) thymus-independent lymphoma cells, found in lobes of normal weight as well as in thymi enlarged by lymphoma cells. Thymocyte characteristics of virus-treated animals of 21 to 63 days of age were compared with those of age-matched controls. Beginning at 28 days a concordant, progressive with time, increase of thymocyte surface staining for the viral envelope glycoprotein gp70 was seen in all lobes from virus-treated animals. Evaluation of cell surface markers by two-color fluorescence with antibodies to CD4 and CD8 showed that after 50 days of age, thymic lobes with and without lymphomas had nonspecific, but marked, alterations of the typical thymocyte surface marker pattern. No characteristic CD4, CD8 surface phenotype was found in primary lymphomas. Using probes for the T-cell receptor J beta 2 gene segments and the Akv ecotropic virus gp70 envelope genes, oligoclonality in J beta 2 rearrangements and clonality using the Akv env genes was demonstrated in thymi with the thymus-dependent phenotype. In lymphomas T-cell receptor beta gene probes showed either oligoclonality or clonality. Clonal virus integrations were found in these lymphomas. These experiments suggest the following series of events in virus-accelerated AKR lymphomagenesis. First, lymphoma cells arise which are initially thymus-dependent and can appear in one or simultaneously in both thymic lobes. These progress to become thymus-independent, fully autonomous, tumor cells. Thymocytes close to or at the time of the initial transformation event show a marked disorder of differentiation defined by the alterations in the CD4, CD8 surface phenotype distribution.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545338

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.

Authors:  F K Yoshimura; T Wang; M Cankovic
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.

Authors:  Karen Rulli; Jack Lenz; Laura S Levy
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.

Authors:  F K Yoshimura; T Wang; F Yu; H R Kim; J R Turner
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.

Authors:  Ditte Ejegod; Karina Dalsgaard Sørensen; Ilona Mossbrugger; Leticia Quintanilla-Martinez; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

5.  A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.

Authors:  Sys Zoffmann Glud; Annette Balle Sørensen; Mindaugas Andrulis; Bruce Wang; Eisaku Kondo; Randi Jessen; Laszlo Krenacs; Eva Stelkovics; Matthias Wabl; Edgar Serfling; Alois Palmetshofer; Finn Skou Pedersen
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

6.  Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.

Authors:  Tim Heinrich; Benjamin Rengstl; Alexander Muik; Mina Petkova; Frederike Schmid; Robin Wistinghausen; Kathrin Warner; Giuliano Crispatzu; Martin-Leo Hansmann; Marco Herling; Dorothee von Laer; Sebastian Newrzela
Journal:  Mol Ther       Date:  2013-04-23       Impact factor: 11.454

7.  Thymic dendritic cells are primary targets for the oncogenic virus SL3-3.

Authors:  C H Uittenbogaart; W Law; P J Leenen; G Bristol; W van Ewijk; E F Hays
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.

Authors:  Karina Dalsgaard Sørensen; Leticia Quintanilla-Martinez; Sandra Kunder; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.

Authors:  Yulan Qing; Stanton L Gerson
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

10.  Post-Irradiation Thymic Regeneration in B6C3F1 Mice Is Age Dependent and Modulated by Activation of the PI3K-AKT-mTOR Pathway.

Authors:  Masaaki Sunaoshi; Benjamin J Blyth; Yi Shang; Chizuru Tsuruoka; Takamitsu Morioka; Mayumi Shinagawa; Mari Ogawa; Yoshiya Shimada; Akira Tachibana; Daisuke Iizuka; Shizuko Kakinuma
Journal:  Biology (Basel)       Date:  2022-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.